Publicaciones en colaboración con investigadores/as de Harvard Medical School (1)

2020

  1. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

    The Lancet Oncology, Vol. 21, Núm. 2, pp. 271-282